A detailed history of 683 Capital Management, LLC transactions in Galapagos Nv stock. As of the latest transaction made, 683 Capital Management, LLC holds 70,000 shares of GLPG stock, worth $1.77 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
70,000
Previous 70,000 -0.0%
Holding current value
$1.77 Million
Previous $1.73 Million 16.21%
% of portfolio
0.18%
Previous 0.16%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$24.78 - $32.48 $297,360 - $389,759
12,000 Added 20.69%
70,000 $1.73 Million
Q2 2023

Aug 14, 2023

SELL
$37.4 - $44.52 $1.35 Million - $1.6 Million
-35,971 Reduced 38.28%
58,000 $2.36 Million
Q1 2023

May 15, 2023

SELL
$36.5 - $48.0 $284,700 - $374,400
-7,800 Reduced 7.66%
93,971 $3.63 Million
Q4 2022

Feb 14, 2023

SELL
$37.44 - $46.51 $786,240 - $976,710
-21,000 Reduced 17.11%
101,771 $4.52 Million
Q3 2022

Nov 14, 2022

SELL
$42.27 - $57.6 $567,305 - $773,049
-13,421 Reduced 9.85%
122,771 $5.24 Million
Q2 2022

Aug 15, 2022

SELL
$52.3 - $71.59 $18.3 Million - $25 Million
-349,808 Reduced 71.98%
136,192 $7.6 Million
Q1 2022

May 16, 2022

SELL
$51.32 - $68.5 $21.5 Million - $28.7 Million
-419,121 Reduced 46.31%
486,000 $30.1 Million
Q4 2021

Feb 14, 2022

BUY
$47.03 - $57.12 $9.58 Million - $11.6 Million
203,700 Added 29.04%
905,121 $49.9 Million
Q3 2021

Nov 15, 2021

BUY
$52.17 - $70.2 $34.9 Million - $46.9 Million
668,098 Added 2004.92%
701,421 $36.9 Million
Q2 2021

Aug 16, 2021

BUY
$68.86 - $83.34 $2.29 Million - $2.78 Million
33,323 New
33,323 $2.3 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.66B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track 683 Capital Management, LLC Portfolio

Follow 683 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.